Home » Topics » Regulatory » Patents

Patents
RSS

Eisai claims novel cytidine deaminase inhibitors for the treatment of cancer

May 21, 2009

Merck KGaA discovers SGLT inhibitors for the treatment of diabetes

May 21, 2009

Janssen claims novel adenosine A2A receptor antagonists for neurodegenerative conditions

May 21, 2009

Exelixis claims the discovery of novel tropane compounds for cancer treatment

May 20, 2009

Roche describes novel phosphatidylinositol 3-kinase inhibitors for cancer treatment

May 20, 2009

Novel mGluR5 receptor antagonists emerge from AstraZeneca R&D

May 20, 2009

Merck & Co. presents novel JAK and PDK1 kinase inhibitors for cancer treatment

May 19, 2009

Suven Life Sciences claims novel 5-HT6 receptor ligands as anxiolytics

May 19, 2009

GE Healthcare describes novel agents for X-ray diagnosis

May 19, 2009

Boehringer Ingelheim reports discovery of chemokine CCR10 receptor antagonists as antipsoriatics

May 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...